WH

Wataru Hirose

SC Sumitomo Pharma Co.: 4 patents #7 of 141Top 5%
SC Sumitomo Dainippon Pharma Co.: 3 patents #34 of 206Top 20%
BB Boston Biomedical: 2 patents #7 of 25Top 30%
SO Sumitomo Dainippon Pharma Oncology: 1 patents #16 of 43Top 40%
Overall (All Time): #480,247 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12410154 5-heteroaryl-1H-pyrazol-3-amine derivative Seiji KAMIOKA, Hitoshi Ban, Makoto Matsuoka, Naoaki SHIMADA, Kento HAYASHI +1 more 2025-09-09
12263167 Optically active azabicyclo ring derivative Seiji KAMIOKA, Hitoshi Ban, Naoaki SHIMADA, Akihiko ARAKAWA, Kazuto Yamazaki +1 more 2025-04-01
11911381 Optically active azabicyclo ring derivative Seiji KAMIOKA, Hitoshi Ban, Naoaki SHIMADA, Akihiko ARAKAWA, Kazuto Yamazaki +1 more 2024-02-27
11564920 5-heteroaryl-1H-pyrazol-3-amine derivative Seiji KAMIOKA, Hitoshi Ban, Makoto Matsuoka, Naoaki SHIMADA, Kento HAYASHI +1 more 2023-01-31
11369605 Optically active azabicyclo ring derivative Seiji KAMIOKA, Hitoshi Ban, Naoaki SHIMADA, Akihiko ARAKAWA, Kazuto Yamazaki +1 more 2022-06-28
11325921 Optically active crosslinked cyclic secondary amine derivative Seiji KAMIOKA, Naoaki SHIMADA, Hitoshi Ban, Akihiko Yokoyama 2022-05-10
11279694 Alvocidib prodrugs and their use as protein kinase inhibitors Adam Siddiqui-Jain, Yusuke Sawayama, Hitoshi Ban 2022-03-22
10815241 Optically active azabicyclo ring derivative Seiji KAMIOKA, Hitoshi Ban, Naoaki SHIMADA, Akihiko ARAKAWA, Kazuto Yamazaki +1 more 2020-10-27
10683274 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof Toshihiko Sone, Naoaki SHIMADA, Chiang Jia Li, Wei Li, David Leggett 2020-06-16
10017488 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof Toshihiko Sone, Naoaki SHIMADA, Chiang Jia Li, Wei Li, David Leggett 2018-07-10